Three things to know:
1. The new reimbursement code for Anjeso is C9059. It is set to take effect July 1 for ASCs and hospital outpatient departments.
2. Baudax Bio announced the new pass-through status and commercial launch of Anjeso June 15.
3. Anjeso gained FDA approval earlier in the year, for use alone or in combination with non-steroidal anti-inflammatory drugs.
More articles on ASCs:
The ‘new normal’ for ASCs: 16 admins on how the pandemic will change the field forever
Dr. Thomas Vikoren: Same-day TJR ‘made all the more important’ by COVID-19
Indiana orthopedic practice with surgery center to open
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
